Zasocitinib showed superiority over placebo in phase 3 trials, achieving rapid and sustained skin clearance in plaque psoriasis. The trials demonstrated a favorable safety profile, with common adverse ...
Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.
The biggest stories of the day delivered to your inbox.
An innovative group of engineers from American powersports company Polaris built a unique vehicle prototype in 2010. This three-wheeled (two up front, one in back), open-cockpit machine looked like a ...
Florida ranks in the top 5 on WalletHub's 2025 list of "most fun" states, trading places with California from the previous year's list. Florida boasts the highest number of restaurants, amusement ...
HONOLULU (KHON2) — Hawaii’s largest infrastructure project is taking another big step, as the project broke ground on the next phase of the Skyline rail project. Around the clock testing starts for ...
Launching a new MMORPG against the long-established giants is a daunting prospect. World of Warcraft, FF14, Guild Wars 2, Runescape, Eve Online; the list goes on, making it a tough task to craft a ...
Abviax's Obefazimod shows promising phase 2b results in ulcerative colitis, with superior safety and efficacy compared to existing treatments, supporting a buy rating. The drug's novel mechanism ...
Pharvaris, a late-stage biopharmaceutical company focused on developing oral bradykinin B2 receptor antagonists for bradykinin-mediated diseases like hereditary angioedema (HAE), has updated the ...
LEXINGTON, Mass.--(BUSINESS WIRE)--#CancerCare--Agenus Inc. (Nasdaq: AGEN) a leader in immuno-oncology innovation, today announced that its botensilimab and balstilimab (BOT/BAL) combination achieved ...
Google Imagen 4, which is the company's state-of-the-art text-to-image model, is rolling out for free, but only on AI Studio. In a blog post, Google announced the rollout of the new Imagen 4 model, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results